Press release
Insights on the Enoxaparin API Market Report & Forecast to 2028 - by Players, Types, Applications and Region
QY Research latest released a report about Enoxaparin API. This report focuses on global and United States Enoxaparin API, also covers the segmentation data of other regions in regional level and county level.Key Market Segmentation
Enoxaparin API is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Enoxaparin API will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Enoxaparin API size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
For more information about this report, visit
https://us.qyresearch.com/reports/355767/enoxaparin-api
Breakup by Type
Multi Vials
Pre-Filled Syringes
Others
Breakup by Application
COVID-19
Pulmonary Embolism
Atrial Fibrillation
Others
Breakup by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Breakup by Company
Pfizer Inc.
Sanofi S.A.
GlaxoSmithKline Plc
Bristol Myer Squibb Company
Bohehringer Ingelheim
Eisai Inc.
Teva Pharmaceutical Industries Ltd.
Abbot India Limited, Novartis AG
ChemWerth
Laboratorios Farmaceuticos ROVI SA
Gland Pharma Limited
Hanways Chempharma Co. Ltd
Changzhou Qianhong Biopharma
Shenzhen Hepalink Pharmaceutical Group
Key Questions Answered in This Report
How has the Global and United States Enoxaparin API performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the Enoxaparin API type?
What is the breakup of the market based on the application?
What is the breakup of the market size based on the region?
What is the breakup of the market based on the region Level & country Level?
What is the structure of the Global and United States Enoxaparin API and who are the key players?
Key Topics Covered:
1 Study Coverage
1.1 Enoxaparin API Product Introduction
1.2 Global Enoxaparin API Outlook 2017 VS 2022 VS 2028
1.2.1 Global Enoxaparin API Sales in US$ Million for the Year 2017-2028
1.2.2 Global Enoxaparin API Sales in Volume for the Year 2017-2028
1.3 United States Enoxaparin API Outlook 2017 VS 2022 VS 2028
1.3.1 United States Enoxaparin API Sales in US$ Million for the Year 2017-2028
1.3.2 United States Enoxaparin API Sales in Volume for the Year 2017-2028
1.4 Enoxaparin API Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Enoxaparin API in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Enoxaparin API Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Enoxaparin API Market Dynamics
1.5.1 Enoxaparin API Industry Trends
1.5.2 Enoxaparin API Market Drivers
1.5.3 Enoxaparin API Market Challenges
1.5.4 Enoxaparin API Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Packaging
2.1 Enoxaparin API Market Segment by Packaging
2.1.1 Multi Vials
2.1.2 Pre-Filled Syringes
2.1.3 Others
2.2 Global Enoxaparin API Market Size by Packaging
2.2.1 Global Enoxaparin API Sales in Value, by Packaging (2017, 2022 & 2028)
2.2.2 Global Enoxaparin API Sales in Volume, by Packaging (2017, 2022 & 2028)
2.2.3 Global Enoxaparin API Average Selling Price (ASP) by Packaging (2017, 2022 & 2028)
2.3 United States Enoxaparin API Market Size by Packaging
2.3.1 United States Enoxaparin API Sales in Value, by Packaging (2017, 2022 & 2028)
2.3.2 United States Enoxaparin API Sales in Volume, by Packaging (2017, 2022 & 2028)
2.3.3 United States Enoxaparin API Average Selling Price (ASP) by Packaging (2017, 2022 & 2028)
3 Market by Application
3.1 Enoxaparin API Market Segment by Application
3.1.1 COVID-19
3.1.2 Pulmonary Embolism
3.1.3 Atrial Fibrillation
3.1.4 Others
3.2 Global Enoxaparin API Market Size by Application
3.2.1 Global Enoxaparin API Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Enoxaparin API Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Enoxaparin API Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Enoxaparin API Market Size by Application
3.3.1 United States Enoxaparin API Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Enoxaparin API Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Enoxaparin API Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Enoxaparin API Competitor Landscape by Company
4.1 Global Enoxaparin API Market Size by Company
4.1.1 Top Global Enoxaparin API Manufacturers Ranked by Revenue (2021)
4.1.2 Global Enoxaparin API Revenue by Manufacturer (2017-2022)
4.1.3 Global Enoxaparin API Sales by Manufacturer (2017-2022)
4.1.4 Global Enoxaparin API Price by Manufacturer (2017-2022)
4.2 Global Enoxaparin API Concentration Ratio (CR)
4.2.1 Enoxaparin API Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Enoxaparin API in 2021
4.2.3 Global Enoxaparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Enoxaparin API Manufacturing Base Distribution, Product Type
4.3.1 Global Enoxaparin API Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Enoxaparin API Product Type
4.3.3 Date of International Manufacturers Enter into Enoxaparin API Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Enoxaparin API Market Size by Company
4.5.1 Top Enoxaparin API Players in United States, Ranked by Revenue (2021)
4.5.2 United States Enoxaparin API Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Enoxaparin API Sales by Players (2020, 2021 & 2022)
5 Global Enoxaparin API Market Size by Region
5.1 Global Enoxaparin API Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Enoxaparin API Market Size in Volume by Region (2017-2028)
5.2.1 Global Enoxaparin API Sales in Volume by Region: 2017-2022
5.2.2 Global Enoxaparin API Sales in Volume Forecast by Region (2023-2028)
5.3 Global Enoxaparin API Market Size in Value by Region (2017-2028)
5.3.1 Global Enoxaparin API Sales in Value by Region: 2017-2022
5.3.2 Global Enoxaparin API Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Enoxaparin API Market Size YoY Growth 2017-2028
6.1.2 North America Enoxaparin API Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Enoxaparin API Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Enoxaparin API Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Enoxaparin API Market Size YoY Growth 2017-2028
6.3.2 Europe Enoxaparin API Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Enoxaparin API Market Size YoY Growth 2017-2028
6.4.2 Latin America Enoxaparin API Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Enoxaparin API Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Enoxaparin API Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Corporation Information
7.1.2 Pfizer Inc. Description and Business Overview
7.1.3 Pfizer Inc. Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Inc. Enoxaparin API Products Offered
7.1.5 Pfizer Inc. Recent Development
7.2 Sanofi S.A.
7.2.1 Sanofi S.A. Corporation Information
7.2.2 Sanofi S.A. Description and Business Overview
7.2.3 Sanofi S.A. Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Sanofi S.A. Enoxaparin API Products Offered
7.2.5 Sanofi S.A. Recent Development
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Corporation Information
7.3.2 GlaxoSmithKline Plc Description and Business Overview
7.3.3 GlaxoSmithKline Plc Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.3.4 GlaxoSmithKline Plc Enoxaparin API Products Offered
7.3.5 GlaxoSmithKline Plc Recent Development
7.4 Bristol Myer Squibb Company
7.4.1 Bristol Myer Squibb Company Corporation Information
7.4.2 Bristol Myer Squibb Company Description and Business Overview
7.4.3 Bristol Myer Squibb Company Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Bristol Myer Squibb Company Enoxaparin API Products Offered
7.4.5 Bristol Myer Squibb Company Recent Development
7.5 Bohehringer Ingelheim
7.5.1 Bohehringer Ingelheim Corporation Information
7.5.2 Bohehringer Ingelheim Description and Business Overview
7.5.3 Bohehringer Ingelheim Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bohehringer Ingelheim Enoxaparin API Products Offered
7.5.5 Bohehringer Ingelheim Recent Development
7.6 Eisai Inc.
7.6.1 Eisai Inc. Corporation Information
7.6.2 Eisai Inc. Description and Business Overview
7.6.3 Eisai Inc. Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Eisai Inc. Enoxaparin API Products Offered
7.6.5 Eisai Inc. Recent Development
7.7 Teva Pharmaceutical Industries Ltd.
7.7.1 Teva Pharmaceutical Industries Ltd. Corporation Information
7.7.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd. Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Teva Pharmaceutical Industries Ltd. Enoxaparin API Products Offered
7.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.8 Abbot India Limited, Novartis AG
7.8.1 Abbot India Limited, Novartis AG Corporation Information
7.8.2 Abbot India Limited, Novartis AG Description and Business Overview
7.8.3 Abbot India Limited, Novartis AG Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Abbot India Limited, Novartis AG Enoxaparin API Products Offered
7.8.5 Abbot India Limited, Novartis AG Recent Development
7.9 ChemWerth
7.9.1 ChemWerth Corporation Information
7.9.2 ChemWerth Description and Business Overview
7.9.3 ChemWerth Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.9.4 ChemWerth Enoxaparin API Products Offered
7.9.5 ChemWerth Recent Development
7.10 Laboratorios Farmaceuticos ROVI SA
7.10.1 Laboratorios Farmaceuticos ROVI SA Corporation Information
7.10.2 Laboratorios Farmaceuticos ROVI SA Description and Business Overview
7.10.3 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Products Offered
7.10.5 Laboratorios Farmaceuticos ROVI SA Recent Development
7.11 Gland Pharma Limited
7.11.1 Gland Pharma Limited Corporation Information
7.11.2 Gland Pharma Limited Description and Business Overview
7.11.3 Gland Pharma Limited Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Gland Pharma Limited Enoxaparin API Products Offered
7.11.5 Gland Pharma Limited Recent Development
7.12 Hanways Chempharma Co. Ltd
7.12.1 Hanways Chempharma Co. Ltd Corporation Information
7.12.2 Hanways Chempharma Co. Ltd Description and Business Overview
7.12.3 Hanways Chempharma Co. Ltd Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Hanways Chempharma Co. Ltd Products Offered
7.12.5 Hanways Chempharma Co. Ltd Recent Development
7.13 Changzhou Qianhong Biopharma
7.13.1 Changzhou Qianhong Biopharma Corporation Information
7.13.2 Changzhou Qianhong Biopharma Description and Business Overview
7.13.3 Changzhou Qianhong Biopharma Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Changzhou Qianhong Biopharma Products Offered
7.13.5 Changzhou Qianhong Biopharma Recent Development
7.14 Shenzhen Hepalink Pharmaceutical Group
7.14.1 Shenzhen Hepalink Pharmaceutical Group Corporation Information
7.14.2 Shenzhen Hepalink Pharmaceutical Group Description and Business Overview
7.14.3 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Shenzhen Hepalink Pharmaceutical Group Products Offered
7.14.5 Shenzhen Hepalink Pharmaceutical Group Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Enoxaparin API Industry Chain Analysis
8.2 Enoxaparin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Enoxaparin API Distributors
8.3 Enoxaparin API Production Mode & Process
8.4 Enoxaparin API Sales and Marketing
8.4.1 Enoxaparin API Sales Channels
8.4.2 Enoxaparin API Distributors
8.5 Enoxaparin API Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Receive Free Sample, Charts, Tables or Full Report, Please enter:
https://us.qyresearch.com/reports/355767/enoxaparin-api
Any questions or requirements, please do not hesitate to contact us.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights on the Enoxaparin API Market Report & Forecast to 2028 - by Players, Types, Applications and Region here
News-ID: 2635255 • Views: …
More Releases from QY Research
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
Global and U.S. Loose Bulk Density Meters Market Report, Published by QY Researc …
Loose Bulk Density Meters are specialized instruments used to measure the mass per unit volume of bulk powders and granular materials in an uncompacted state. These devices help determine flowability, packing behavior, and quality control parameters critical in industries such as pharmaceuticals, chemicals, food processing, and construction materials. Measurement methods typically involve automated funnels, weighing platforms, and volume displacement chambers to ensure reproducibility.
https://www.qyresearch.com/reports/4937970/loose-bulk-density-meters
The global Loose Bulk Density Meters market reached…
Global and U.S. Interactive Visual Presenters Market Report, Published by QY Res …
Interactive Visual Presenters, also known as document cameras or digital visualizers, are teaching and presentation tools that project real-time images of documents, 3D objects, or live demonstrations onto large displays through HDMI, USB, or wireless interfaces. Equipped with high-resolution cameras, LED lighting, zoom, and annotation functions, they are widely used in classrooms, corporate training, and hybrid learning environments.
https://www.qyresearch.com/reports/4941119/interactive-visual-presenters
The global Interactive Visual Presenters market reached USD 584 million in 2024, growing…
Commercial Three Phase Micro Inverter Market to CAGR 12,4% by 2031 Top 10 Compan …
The global commercial three phase micro inverter market is witnessing accelerated adoption as industries and commercial establishments embrace renewable energy solutions for cost efficiency, grid stability, and sustainability. Micro inverters, which convert direct current (DC) from solar panels into alternating current (AC) at the individual panel level, are increasingly being used in commercial three phase setups for enhanced efficiency, safety, and scalability. Unlike string inverters, three phase micro inverters offer…
More Releases for Enoxaparin
Enoxaparin API Market Demand Driven by Healthcare Needs | Persistence Market Res …
✅ Market Overview: Trends, Statistics, and Growth Drivers
The Enoxaparin API market has gained substantial momentum in recent years, largely fueled by a surge in global demand for anticoagulant therapies. Enoxaparin, a low molecular weight heparin (LMWH), is widely used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and acute coronary syndromes. Its inclusion in the World Health Organization's list of essential medicines underlines…
Comprehensive Report on an Enoxaparin Manufacturing Plant Project: Cost and Reve …
Setting up an enoxaparin manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Enoxaparin Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing an enoxaparin manufacturing plant, covering…
Enoxaparin Sodium APIs and Preparations Market 2024-2030: Global Trends, Key Ins …
Enoxaparin Sodium APIs and Preparations - Market Size
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium APIs and Preparations, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enoxaparin Sodium APIs and Preparations…
Global Enoxaparin API Market Report: Innovations and Regional Analysis for 2024- …
Enoxaparin API Market Size
The global market for Enoxaparin API was estimated to be worth US$ 670 million in 2023 and is forecast to a readjusted size of US$ 1001.5 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030.
North American market for Enoxaparin API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period…
Enoxaparin Sodium Market : Size, Share, Growth, Analysis, Key Players, Revenue, …
Enoxaparin Sodium Market Size
The global Enoxaparin Sodium market was valued at US$ 3315 million in 2023 and is anticipated to reach US$ 5415 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-6L9458/Global_Enoxaparin_Sodium_Market_Insights_and_Forecast_to_2028
Enoxaparin Sodium Market
Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of…
Enoxaparin Sodium Market Revenue, Insights, Overview, Outlook, Analysis | Valuat …
Enoxaparin Sodium Market
The global Enoxaparin Sodium market was valued at US$ 3044.5 million in 2022 and is anticipated to reach US$ 5354.7 million by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029.
Get Free Research Report: https://reports.valuates.com/request/sample/QYRE-Auto-6L9458/Global_Enoxaparin_Sodium_Market_Insights_and_Forecast_to_2028
Enoxaparin Sodium Market Share
Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in…
